Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Graham Phillips, Mba is listed as Chief Operating Officer at Endologix LLC, based in Greater Minneapolis-St. Paul Area, United States. AeroLeads shows a matched LinkedIn profile for Graham Phillips, Mba.
Graham Phillips, Mba previously worked as Vice President Manufacturing, Americas East Region at Medtronic and Vice President Manufacturing, Electronic Technologies & China at Medtronic. Graham Phillips, Mba holds Mba from University Of Warwick - Warwick Business School.
This section adds company-level context without repeating Graham Phillips, Mba's masked contact details.
Review company-level records connected to Graham Phillips, Mba before choosing the right outreach path.
I am the Chief Operating Officer at Endologix, a global medical device company dedicated to improving patients’s lives by providing innovative therapies for the interventional treatment of vascular disease. At Endologix I oversee quality, regulatory, R&D, plan, source, make and deliver functions. I am a accomplished Operations Leader known for driving transformative change at both strategic and tactical levels, spearheading restructuring, cost-saving initiatives, and new product introductions across the end-to-end supply chain in the Medical Devices and Consumer Packaged Goods (CPG) industries. Extensive and progressive expertise in Manufacturing Operations, PMO, and Engineering roles across Europe, Asia, Latin America and the U.S., with key experience in R&D, Tax, and Supply Chain leadership. Prior to Endologix I held several high impact executive positions at Medtronic, in global operations, supply chain management, and strategic leadership. As Vice President Manufacturing I lead 25 sites globally delivering outstanding business results through the implementation of a tier management system that drives engagement and accountability.As Vice President of Global Supply Chain at Medtronic, I led a 3k+ team responsible for planning, transportation, warehousing and trade compliance supporting over $30 billion in revenue. I successfully managed supply during Covid-19, the Ukraine-Russia war outbreak while also leading the consolidation of nine departments to one.In my role as Vice President Global Operations for various sectors including General Surgery, Cardiac Rhythm, and Structural Heart, I consistently drove excellence in execution and financial performance. I eliminated FDA warning letters, launched products, optimized supply and achieved substantial cost savings while improving margins.Throughout my career I have led transformative initiatives that have significantly impacted business performance including leading integrations, spin-offs, new venture creation, rewiring the legal entity and associated tax structure and R&D creation in Asia. My track record reflects a deep commitment to operational excellence, strategic vision, and driving sustainable growth in dynamic business environments.My approach to leadership goes beyond delivering results; it involves empowering teams to tackle their hardest problems collaboratively and strategically. I believe in taking a hands-on approach, whether it's solving complex irrational operations problems or providing guidance on navigating new learning cycles and positively reinforcing team performance.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Irvine, Ca, Us
Endologix is a global medical device company dedicated to improving patients’s lives by providing innovative therapies for the interventional treatment of vascular disease. At Endologix I oversee quality, regulatory, R&D, plan, source, make and deliver functions.
Minneapolis, Mn, Us
Lead 25 manufacturing sites across three continents in six jurisdictions, delivering ~$17B of revenue with a team of ~15000 reports. I am responsible for ensuring manufacturing performance excellence in People, Safety, Quality, Supply and Cost metrics. LEADING TEAMS – Lead a large global dispersed team to deliver outstanding KPIs with a tier management system that drives consistency of focus on the critical few metrics and critical few problems to prioritize and fix. PEOPLE DEVELOPMENT – Championed the development of female site leaders increasing representation and lowered the education requirements for supervisors.QUALITY IMPROVEMENT – Halved the number of non-conforming products and delivered zero FDA class one field actions. STRATEGY SETTING – Implemented a new bonus system for hourly staff that was a driver of improved productivity performance.REVENUE GROWTH – Ramped up the critical new pulse field ablation product launch. Expanded production of critical suture, neurological and orthopedic human tissue-based products.VALUE CREATION - Led the integration of an acquired manufacturing site in MI, transferred production to lower labor location and closure of two manufacturing facilities in CA.COST REDUCTION – Reduced overhead by 4.8%. Reduced Raw Material and Work in Progress inventory by over 25%.EXECUTING FOR RESULTS – Standardized 5S, tier management, visual management, Gemba, and problem-solving methodologies to leverage the scale of the organization to improve uptime, yield, and quality performance. This in turn delivered world class safety, quality, service, and cost results.
Minneapolis, Mn, Us
Accountable for Manufacturing across 13 manufacturing sites on 3 continents, in 6 jurisdictions, spanning 15 time zones, with a team of ~10500, delivering ~$9Bn of revenue.LEADING TEAMS - Remotely led five facilities in China to maintain continuity of supply from facilities through COVID-19 restrictions.QUALITY IMPROVEMENT - Part of the team that resolved a long running complex FDA warning letter against the Medtronic Diabetes business.STRATEGY SETTING - Implemented significant salary changes to maintain workforce levels in a competitive marketplace for hourly workers and developed site leaders to manage these situations in multiple geographies.REVENUE GROWTH – Ramped up production output of critical new product technologies (stacked plate battery implantable defibrillators and silicon wafer integrated circuit diagnostic devices). VALUE CREATION - Removed raw material constraints to production back to pre-COVID-19 levels improving customer supply. COST REDUCTION – Reduced overhead by 3.9%. And reduced yield loss on a specific problematical product line by $20MEXECUTING FOR RESULTS – Negotiated tax agreements in multiple locations.
Minneapolis, Mn, Us
Accountable for Planning, Transportation, Warehousing, and Trade activities supporting all of Medtronic’s ~$30Bn+ revenue.LEADING TEAMS - Led a team of ~3000 across 59 Distribution Centers in 40 countries supporting ~$30B+ revenue.STRATEGY SETTING - Devised a solution to consolidate warehouses in the US to drive operational efficiency.COST REDUCTION – Took nine supply chain departments into one enterprise organization. Obtained funding from BOD to improve demand/supply planning processes, improving work efficiency, working capital and revenue realization.EXECUTING FOR RESULTS – Maintained continuity of supply even though facing challenges coming from COVID-19 general supply chain limitations and geopolitical issues like the commencement of the Russia-Ukraine War.
Minneapolis, Mn, Us
Responsible for leading a team of ~10000 across 21 manufacturing sites in 9 countries supporting ~$8.3Bn+ revenue covering Plan, Source & Make. LEADING TEAMS - Implemented a robust approach to prioritizing resources using tier management strategy deployment and OEE to measure waste elimination activities to drive performance. PEOPLE DEVELOPMENT - Deployed goals ubiquitously across the organization to drive accountability for the Cost of Goods on the P&L and Excellence in Execution. STRATEGY SETTING - Sat on the staff of Executive Committee Members for both Operations and Commercial functions contributing to the 5-year roadmap for both organizations.EXECUTING FOR RESULTS – Achieved financial predictability with acute attention to fiscal basics avoiding a large loss experienced in the prior 3 years.
Minneapolis, Mn, Us
Led 6k+ team across 15 manufacturing sites in six countries supporting ~$5.7B+ revenue. Served 1M patients annually with implantable pacing & defibrillation and ablation covering Plan, Source & Make. LEADING TEAMS - Improved diversity of leadership in Operations and advocated for the young professional community. QUALITY IMPROVEMENT - Eliminated three FDA Warning Letters driving product availability to world class levels. STRATEGY SETTING - Established strategic direction for Operations to support revenue and EBITDA ensuring the team delivered tactically. Grew revenue, gross margin and net margin. REVENUE GROWTH – Launched 30+ products including both incremental and breakthrough innovations VALUE CREATION - Set up continuity of supply covering 80% of revenue. Recovered from the Hurricane Maria natural disaster in Puerto Rico impacting two facilities without revenue impact.EXECUTING FOR RESULTS – Drove 4% of annualized run rate savings and an additional free cash flow.
Minneapolis, Mn, Us
Led a team of ~3000 across 10 manufacturing sites in six countries driving stabilization and creating a cost-down roadmap.STRATEGY SETTING - Devised a Core versus Context methodology to prioritize long-range investments and short-term priorities.VALUE CREATION - Setup operations in China, to source and fixate tissue, supplementing constrained supply. Resolved supply of Cardiac Surgery products from a key contract manufacturing thus eliminating backlog. EXECUTING FOR RESULTS - Implemented long-range planning for transcatheter valve manufacturing which drove the scaling of operations hiring an additional 1000 staff in Mexico to deliver global market expansion.
Minneapolis, Mn, Us
Led OpEx, Engineering, and PMO professionals across the largest franchise (the Surgical business) at Medtronic. Introduced a program for Lean Six Sigma accreditation for master black, black, green, blue, and yellow. Introduced a strategic planning process to operations. Rolled-out a key Quality initiative across enterprise operations in Medtronic
Fridley, Minnesota, Us
Established the Operations function for a new business Covidien wanted to create to sell reprocessed Medical Devices.Built a factory in Tampa FL. Devised the process the enter US hospitals and retrieve used Medical Devices and ship back to Tampa, FL. Acquired internal and external talent to create the Operations function. Created reprocessing processes and obtained FDA approval for reprocessing and sale Medical Devices. Started generating revenue and profit. From the announcement of Medtronic’s intention to purchase Covidien until 6 months post acquisition led the integration of Covidien Operations into Medtronic. Covidien was a $11Bn revenue business with over 50 manufacturing plants, 50+ distribution centers and 3500+ suppliers.
Fridley, Minnesota, Us
Managed Corporate Engineering, PMO, and the Quality Improvement Program. Managed the $550M capital budget at Covidien. Responsible for engineering rigor across operations including improving the execution of the Quality system and Quality Culture. Led the operations strategic planning process and the operations element of the Mallinckrodt Pharmaceuticals spin-off. Led opening of new Surgical Training Centers in Brazil, Turkey, China, India, Saudi Arabia, and Indonesia. Set up R&D centers in India, Singapore, and China. Worked with the Tax department to change the tax and legal entity structure of Covidien to allow the spin-off of Mallinckrodt Pharmaceuticals.
Fridley, Minnesota, Us
Worked with the Tax department to change the tax and legal entity structure of Covidien to allow the divestiture or spin-off of Mallinckrodt Pharmaceuticals and the potential acquisition of the organizationSet up R&D centers in Hyderabad, India, Singapore and Shanghai, China
Fridley, Minnesota, Us
Managed a team of Project Managers to deliver projects. Moved Covidien Corporate HQ from Bermuda to Dublin Ireland and led a factory capacity expansion in France. Led the team managing the closure of seven plants in five countries through EMEA. Led the rebranding of Tyco Healthcare to Covidien, OUS and numerous product transfers between plants.
Quick answers generated from the profile data available on this page.
Graham Phillips, Mba works for Endologix LLC.
Graham Phillips, Mba is listed as Chief Operating Officer at Endologix LLC.
Graham Phillips, Mba is based in Greater Minneapolis-St. Paul Area, United States while working with Endologix LLC.
Graham Phillips, Mba has worked for Endologix Llc, Medtronic, Covidien, Budelpack, and Kraft Foods.
You can use AeroLeads to view verified contact signals for Graham Phillips, Mba at Endologix LLC, including work email, phone, and LinkedIn data when available.
Graham Phillips, Mba holds Mba from University Of Warwick - Warwick Business School.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts